Immucor's IBD Statistics Update
Mason,
Thanks for the response and opinion. I still believe that we may see
some action on the acquisition or alliance front down the road. Time
will tell.
By the by, Immucor's statistics regarding EPS, Relative Strength,
Accumulation Distribution, etc. as published in the NASDAQ Tables of
Investor's Business Daily on Monday, August 17, 1998 indicate recent
weakness. It may be a good time to buy some more shares as the price
is at the low end of the trading range.
Take a look....
Category July 17th August 17th
EPS Rank 78 79 (Up)
Relative Strength 70 64* (Down)
Accumulation Distribution B C* (Down)
Annual Earnings Growth +11% +11%
Quarter EPS Change +20% +20%
Quarter Sales Change +5% +5%
Group Rank B N/A
Legend
EPS Rank - Measures a company's earnings per share growth in the last
5 years and the stability of that growth. The %change in the last two
quarters' earnings vs. same quarters a year earlier is combined and
averaged with the 5 year record. Result is compared to all companies
in the tables and ranked on a scale of 1 to 99, with 99 the highest.
A 90 rank means the company produced earnings in the top 10%. Companies
with superior earnings records rank 80 or higher.
Relative Price Strength - Measures daily each stock's relative price
change over the last 12 months compared to all other stocks in the
tables. Results are ranked 1 to 99. Stocks ranking below 70 indicate
weaker or more laggard relative performance.
Accumulation Distribution - Rating takes into account the percent
change in a stock's daily price and its volume. "A" is strongest "E"
is weakest. Accumulation-Distribution should be used with other
fundamental and technical factors to determine investment decisions.
Lets go Immucor!
Regards,
Tom |
